BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26462519)

  • 1. [Epigenetic alterations in cervical cancer progression].
    Ríos-Romero M; Soto-Valladares AG; Piña-Sánchez P
    Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S212-7. PubMed ID: 26462519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics and cervical cancer: from pathogenesis to therapy.
    Fang J; Zhang H; Jin S
    Tumour Biol; 2014 Jun; 35(6):5083-93. PubMed ID: 24554414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer.
    Bhat S; Kabekkodu SP; Noronha A; Satyamoorthy K
    Biochimie; 2016 Feb; 121():298-311. PubMed ID: 26743075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
    Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
    J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in epigenetic modifications and cervical cancer research.
    Liu H; Ma H; Li Y; Zhao H
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188894. PubMed ID: 37011697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic alterations in cervical carcinogenesis.
    Szalmás A; Kónya J
    Semin Cancer Biol; 2009 Jun; 19(3):144-52. PubMed ID: 19429477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics of cervical cancer. An overview and therapeutic perspectives.
    Dueñas-González A; Lizano M; Candelaria M; Cetina L; Arce C; Cervera E
    Mol Cancer; 2005 Oct; 4():38. PubMed ID: 16248899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV.
    Wang KH; Lin CJ; Liu CJ; Liu DW; Huang RL; Ding DC; Weng CF; Chu TY
    Cancer Med; 2015 Jan; 4(1):43-55. PubMed ID: 25418975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation changes in cervical cancers.
    Lu Q; Ma D; Zhao S
    Methods Mol Biol; 2012; 863():155-76. PubMed ID: 22359292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer.
    Kabekkodu SP; Chakrabarty S; Ghosh S; Brand A; Satyamoorthy K
    Public Health Genomics; 2017; 20(2):100-115. PubMed ID: 28521327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
    Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
    Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
    Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
    Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt.
    Thabet M; Hemida R; Hasan M; Elshamy M; Elfaraash M; Emam M
    J Exp Ther Oncol; 2014; 10(4):247-53. PubMed ID: 25509977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis.
    de Freitas AC; Coimbra EC; Leitão Mda C
    Biochim Biophys Acta; 2014 Apr; 1845(2):91-103. PubMed ID: 24388872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific type epigenetic changes in cervical cancers.
    Zhao S
    Methods Mol Biol; 2015; 1238():733-49. PubMed ID: 25421689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6-E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: a mechanistic study including molecular docking.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2014 Dec; 744():132-46. PubMed ID: 25448308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.